Inhibitory effects of propiverine hydrochloride on the agonist-induced or spontaneous contractions of various isolated muscle preparations
- PMID: 1418036
Inhibitory effects of propiverine hydrochloride on the agonist-induced or spontaneous contractions of various isolated muscle preparations
Abstract
Inhibitory effects of propiverine hydrochloride (P-4, CAS 60569-19-9), a new drug which reduces the frequency of micturition, were studied on the agonist-induced or spontaneous contractions of various isolated muscle preparations. P-4 (10(-6)-10(-4) mol/l) inhibited both the KCl-induced contractions of isolated guinea-pig urinary bladder and ileum, and its IC50 values (mol/l) were 1.8 +/- 0.3 x 10(-5) (urinary bladder) and 1.3 +/- 0.4 x 10(-5) (ileum), respectively. The spontaneous contractions of isolated guinea-pig atrium, rat uterus and rabbit duodenum were unaffected by P-4 at 10(-6) mol/l, but they were inhibited by the drug at 10(-5)-10(-4) mol/l. Its IC50 values (mol/l) were 10(-4) greater than (guinea-pig atrium), 1.3 +/- 0.3 x 10(-4) (rat uterus), and 1.0 +/- 0.5 x 10(-4) (rabbit duodenum), respectively. P-4 (10(-5)-10(-4) mol/l) inhibited the KCl-induced contraction of isolated rabbit aorta and the histamine-induced contraction of isolated guinea-pig tracheal chain. P-4 (10(-4) mol/l) also inhibited the noradrenaline-(norepinephrine) induced contractions of isolated guinea-pig urethra and vas deferens. In these isolated muscle preparations, the values of IC50 (greater than 10(-4) mol/l) could not be calculated. These results indicate that the inhibitory activities of P-4 on urinary bladder and ileum are 10 to 100 times more potent than those on other organs.
Similar articles
-
Effects of propiverine hydrochloride on the spontaneous contractions of isolated guinea-pig urinary bladder strip and rhythmic urinary bladder contractions of anesthetized dog.Arzneimittelforschung. 1992 Dec;42(12):1459-61. Arzneimittelforschung. 1992. PMID: 1288511
-
Pharmacological effects of propiverine and its active metabolite, M-1, on isolated human urinary bladder smooth muscle, and on bladder contraction in rats.Int J Urol. 2008 Jan;15(1):76-81. doi: 10.1111/j.1442-2042.2007.01927.x. Int J Urol. 2008. PMID: 18184179
-
General pharmacological properties of the new vasodilator flosequinan.Arzneimittelforschung. 1992 Oct;42(10):1200-11. Arzneimittelforschung. 1992. PMID: 1472141
-
Effects of the non-peptide B2 antagonist FR173657 on kinin-induced smooth muscle contraction and relaxation, vasoconstriction and prostaglandin release.Br J Pharmacol. 1997 Jun;121(3):469-76. doi: 10.1038/sj.bjp.0701159. Br J Pharmacol. 1997. PMID: 9179388 Free PMC article.
-
General pharmacology of the new antimuscarinic compound vamicamide.Arzneimittelforschung. 1995 Dec;45(12):1274-84. Arzneimittelforschung. 1995. PMID: 8595084
Cited by
-
[Overactive bladder--treatment with antimuscarinic agents].Urologe A. 2003 Jun;42(6):793-800. doi: 10.1007/s00120-003-0363-y. Epub 2003 May 20. Urologe A. 2003. PMID: 12851770 Review. German.
-
[Overactive bladder syndrome in children].Urologe A. 2004 Jul;43(7):807-12. doi: 10.1007/s00120-004-0625-3. Urologe A. 2004. PMID: 15197448 Review. German.
-
Current pharmacotherapy of overactive bladder.Int Braz J Urol. 2021 Nov-Dec;47(6):1091-1107. doi: 10.1590/S1677-5538.IBJU.2021.99.12. Int Braz J Urol. 2021. PMID: 34003613 Free PMC article. Review.
-
Propiverine and metabolites: differences in binding to muscarinic receptors and in functional models of detrusor contraction.Naunyn Schmiedebergs Arch Pharmacol. 2006 Nov;374(2):87-97. doi: 10.1007/s00210-006-0103-0. Epub 2006 Oct 20. Naunyn Schmiedebergs Arch Pharmacol. 2006. PMID: 17053897